Cardiology Continuing Medical Education

Episodes 1-16 of 115

Trade off: Ischemic/Thrombotic vs Bleeding  
Trade off: Ischemic/Thrombotic vs Bleeding  
MinuteCE®
Trade off: Ischemic/Thrombotic vs Bleeding  
1.00 program credit
- Renato D. Lopes, MD, MHS, PhD
1.00 program credit
Patient Case Study: Cancer-Associated Thrombosis
Patient Case Study: Cancer-Associated Thrombosis
MinuteCE®
Patient Case Study: Cancer-Associated Thrombosis
1.00 program credit
- Renato D. Lopes, MD, MHS, PhD
- Alexander T. Cohen, MD, MBBS
1.00 program credit
Setting the Stage of Real-World Data vs RCT
Setting the Stage of Real-World Data vs RCT
MinuteCE®
Setting the Stage of Real-World Data vs RCT
1.00 program credit
- Renato D. Lopes, MD, MHS, PhD
1.00 program credit
Implications Associated With Integrating Both Real-World Data and Clinical Trial Data Into Clinical Practice: AF Considerations
Implications Associated With Integrating Both Real-World Data and Clinical Trial Data Into Clinical Practice: AF Considerations
MinuteCE®
Implications Associated With Integrating Both Real-World Data and Clinical Trial Data Into Clinical Practice: AF Considerations
1.00 program credit
- Valeria Caso, MD, PhD
1.00 program credit
MinuteCE®
AF and VTE: Global Considerations in the Evolving Space of Real-World Data
1.00 credit 10 episodes
- Renato D. Lopes, MD, MHS, PhD
- Valeria Caso, MD, PhD
- Alexander T. Cohen, MD, MBBS
1.00 credit 10 episodes
Patient Case Study: Obesity and VTE
Patient Case Study: Obesity and VTE
MinuteCE®
Patient Case Study: Obesity and VTE
1.00 program credit
- Renato D. Lopes, MD, MHS, PhD
- Alexander T. Cohen, MD, MBBS
1.00 program credit
How Do We Translate Real-World VTE Data Into Everyday Clinical Practice for Ongoing Anticoagulation?
How Do We Translate Real-World VTE Data Into Everyday Clinical Practice for Ongoing Anticoagulation?
MinuteCE®
How Do We Translate Real-World VTE Data Into Everyday Clinical Practice for Ongoing Anticoagulation?
1.00 program credit
- Alexander T. Cohen, MD, MBBS
1.00 program credit
How Do We Translate Real-World AF Data Into Everyday Clinical Practice?
How Do We Translate Real-World AF Data Into Everyday Clinical Practice?
MinuteCE®
How Do We Translate Real-World AF Data Into Everyday Clinical Practice?
1.00 program credit
- Renato D. Lopes, MD, MHS, PhD
- Valeria Caso, MD, PhD
1.00 program credit
Patient Case Study: Elderly
Patient Case Study: Elderly
MinuteCE®
Patient Case Study: Elderly
1.00 program credit
- Renato D. Lopes, MD, MHS, PhD
- Valeria Caso, MD, PhD
1.00 program credit
Patient Case Study: Obesity
Patient Case Study: Obesity
MinuteCE®
Patient Case Study: Obesity
1.00 program credit
- Renato D. Lopes, MD, MHS, PhD
- Valeria Caso, MD, PhD
1.00 program credit
Implications Associated With Integrating Both Real-World Data and Clinical Trial Data Into Clinical Practice: VTE Considerations
Implications Associated With Integrating Both Real-World Data and Clinical Trial Data Into Clinical Practice: VTE Considerations
MinuteCE®
Implications Associated With Integrating Both Real-World Data and Clinical Trial Data Into Clinical Practice: VTE Considerations
1.00 program credit
- Alexander T. Cohen, MD, MBBS
1.00 program credit
Right Heart Catheterization: Mastery of Precision Techniques
Right Heart Catheterization: Mastery of Precision Techniques
CME/CE Broadcast Replay
Right Heart Catheterization: Mastery of Precision Techniques
1.00 credit
- Richard Krasuski, MD
- Vallerie V. McLaughlin, MD
1.00 credit
The Importance of PD-L1 Testing: Shaping the Future of Treatment in ESCC
The Importance of PD-L1 Testing: Shaping the Future of Treatment in ESCC
MinuteCE®
The Importance of PD-L1 Testing: Shaping the Future of Treatment in ESCC
0.75 program credits
- Harry Yoon, MD
0.75 program credits
Risk Assessment in Pulmonary Hypertension: Practice Trends and Updates
Risk Assessment in Pulmonary Hypertension: Practice Trends and Updates
CME/CE Broadcast Replay
Risk Assessment in Pulmonary Hypertension: Practice Trends and Updates
1.00 credit
- Robert P. Frantz, MD, FACC
- Vallerie V. McLaughlin, MD
- Sonja Bartolomei, MD
1.00 credit
Effective Monitoring and Management of Adverse Effects in Metastatic ESCC
Effective Monitoring and Management of Adverse Effects in Metastatic ESCC
MinuteCE®
Effective Monitoring and Management of Adverse Effects in Metastatic ESCC
0.75 program credits
- Harry Yoon, MD
- Jaffer Ajani, MD
0.75 program credits
MinuteCE®
Differentiating First-Line Treatment Selection: Combination Immunotherapy and Chemotherapy Regimens for Metastatic ESCC
0.75 credits 3 episodes
- Harry Yoon, MD
- Jaffer Ajani, MD
0.75 credits 3 episodes

Prev
1
2
3
…
7
8
Next

1/6